Accretion Nutraveda Limited (ANL.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹271.80 (+0.00%) as of
Key statistics
- Market cap
- 1.97B
- P/E (TTM)
- 29.07
- EPS (TTM)
- 9.35
- Dividend yield
- 0.00%
- 52-week range
- 150.10 – 313.00
- Revenue (TTM)
- 336.15M
- Profit margin
- 15.08%
- Volume
- 2.00k
About Accretion Nutraveda Limited
Accretion Nutraveda Limited manufactures and supplies ayurvedic, nutraceutical, and wellness formulations in India and internationally. The company offers nutraceuticals products, including formulation for brain, memory and neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, git care, effervescent, joint and bone care, immunity booster, gynec care, hair, skin, nail care, and infertility and PCOS care. It also provides ayurvedic products for bone and joint, respiratory, gynec, aphrodisiac, skin, digestive, hair, urinary track, systemic, and nasal congestion and pain, care, as well as single herbs and baby products. The company offers its products in tablets, capsule, syrup, sachet, powder, drops, dry syrup, oral spray, oil/ointment, granules, asav-arishta, cream, facewash/scrub, body massage oil, shampoo, gel, gripe water, balm, and inhaler pack forms. In addition, it provides end-to-end solutions, including product development, formulation support, manufacturing, packaging, and private-label services. Accretion Nutraveda Limited was incorporated in 2021 and is headquartered in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Ahmedabad, India
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.